Hip and knee replacement surgeries within the National Health Service are facing potential disruption due to a critical shortage of bone cement, a vital component used in joint replacement procedures. Several NHS trusts have begun emergency prioritization protocols, according to reports surfacing this week.
The supply issues, which emerged earlier this month, stem from problems with the availability of the cement itself, used to secure implants during surgery. The Times reported that the shortage is impacting the ability of hospitals to schedule routine operations, with some warning that existing stocks may only last for a matter of weeks.
The Guardian detailed the growing concern among orthopedic surgeons, who are being forced to assess patients based on clinical need, postponing less urgent cases. The prioritization is intended to ensure that patients requiring the most immediate intervention are not unduly delayed, but it inevitably leads to longer waiting lists for those with less acute conditions.
BBC News reported that NHS England has acknowledged the supply problems and is working with manufacturers to resolve the issue. However, a firm timeline for restoring normal supply levels has not been established. The disruption affects both planned and emergency joint replacement surgeries, placing additional strain on already stretched healthcare resources.
politicsuk.com highlighted the potential financial implications of the shortage, noting that delays in elective surgeries can lead to increased costs associated with managing chronic pain and reduced mobility. The long-term impact on patient outcomes remains uncertain, but healthcare professionals are concerned about the potential for deterioration in patients’ conditions while they await surgery.
The precise cause of the bone cement shortage has not been publicly disclosed, but industry sources suggest that manufacturing delays and logistical challenges are contributing factors. NHS England has not released detailed information regarding the specific manufacturers affected or the extent of the supply chain disruption.
As of Thursday, February 19, 2026, NHS England has not issued a comprehensive statement outlining contingency plans or alternative sourcing strategies. The Department of Health and Social Care has yet to comment on the situation.
